Radiation Oncology

Radiation oncology is a medical specialty that uses radiation therapy to treat cancer. The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

A 63-year-old multiple #myeloma patient, with skeletal pain. New #FDG avid axillary #lymphadenopathy 62 days (9 weeks) after second #mRNA #vaccination dose. Image used with permission of the Radiological Society of North America (#RSNA)
Feature | Coronavirus (COVID-19) | By Melinda Taschetta-Millane
Help Spread Awareness of Potential COVID-19 Vaccine Imaging Side-effects

Ever so slowly, we are beginning to see some light at the end of the pandemic’s tunnel. Vaccines are now more easily ...

Time April 29, 2021
arrow
A phase 1 clinical trial led by investigators at the University of Chicago Medicine testing the effects of stereotactic body radiotherapy for treating multiple metastases has determined that treatments used for single tumors can also be safely used for treating patients with multiple metastases.
News | Stereotactic Body Radiation Therapy (SBRT)
Study Finds Stereotactic Body Radiotherapy Safe for Treating Patients with Multiple Metastases

April 23, 2021 — A phase 1 clinical trial led by investigators at the University of Chicago Medicine testing the effects ...

Time April 23, 2021
arrow
A Norwegian study for the first time reveals benefit of the #PARP inhibitor #Olaparib in patients with early #breastcancer not harboring germline mutations
News | Radiation Therapy
New Study Reveals Targeted Therapy Working in Early Breast Cancer

April 22, 2021 — Targeted therapy in early stages of breast cancer can pave the way for a notable higher success rate ...

Time April 22, 2021
arrow
olecular Targeting Technologies, Inc. (MTTI) announced the issuance of United States Patent # 10,953,113. The patent claims a quick (5 min), easy and quantitative conversion of commercially available 18F-deoxyglucose (18F-FDG) to 18F-Fluroglucaric acid (18F-FGA).
News | PET Imaging
Molecular Targeting Technologies, Inc. Announces New PET Imaging Agent

April 19, 2021 — Molecular Targeting Technologies, Inc. (MTTI) announced the issuance of United States Patent # 10,953 ...

Time April 19, 2021
arrow
#SiemensHealthineers #Varian #Siemens The transformative combination accelerates the company’s impact on #global #healthcare and establishes a strong partner for #customers and #patients along the entire #cancer care continuum and for many of the most threatening #diseases
News | Radiology Business
Siemens Healthineers Completes Acquisition of Varian

April 15, 2021 — Siemens Healthineers AG announced that it has successfully completed the acquisition of Varian Medical ...

Time April 15, 2021
arrow
The U.S. Food and Drug Administration (#FDA) authorized marketing of #Medtronic's #GIGenius, the first device that uses #artificialintelligence (#AI) based on #machinelearning to assist #clinicians in detecting #lesions (such as #polyps or suspected tumors) in the #colon in real time during a c#olonoscopy.
News | Artificial Intelligence
FDA Authorizes Marketing of First Device that Uses AI to Help Detect Potential Signs of Colon Cancer

April 12, 2021 — The U.S. Food and Drug Administration (FDA) authorized marketing of Medtronic's GI Genius, the first ...

Time April 12, 2021
arrow
3-D mammography reduces the number of breast cancer cases diagnosed in the period between routine screenings, when compared with traditional mammography, according to a large study from Lund University in Sweden. The results are published in the journal Radiology.
News | Breast Imaging
Fewer Breast Cancer Cases Between Screening Rounds with 3-D Mammography

April 9, 2021 — 3-D mammography reduces the number of breast cancer cases diagnosed in the period between routine ...

Time April 09, 2021
arrow
Varian announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) based diagnostic platform to aid in the fight against cancer. Varian and Google Cloud AI embarked on a deployment journey, using Neural Architecture Search (NAS) technology via Google Cloud AI Platform, to create AI models for organ segmentation — a crucial and labor-intensive step in radiation oncology that can be a bottleneck in the cancer treatment clinical workflow.
News | Artificial Intelligence
Varian and Google Cloud Collaborate to Aid in the Fight Against Cancer

April 8, 2021 — Varian announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) ...

Time April 08, 2021
arrow
Mobidiag Oy, a privately held, commercial-stage Finnish-French developer of innovative molecular diagnostic tests and instrumentation, announced today that it has signed a definitive agreement to be acquired by Hologic, Inc., a global leader in women's health, for an enterprise value of approximately $795 million.  This includes a cash payment of approximately $714 million for Mobidiag’s equity, and net debt of approximately $81 million.
News | Women's Health
Mobidiag to be Acquired by Hologic for $795M

April 8, 2021 — Mobidiag Oy, a privately held, commercial-stage Finnish-French developer of innovative molecular ...

Time April 08, 2021
arrow
Brain tumors edged out by artificial intelligence: VBrain applies auto-contouring to the three most common types of brain tumors: brain metastasis, meningioma and acoustic neuroma.
News | Artificial Intelligence
Vysioneer Receives FDA Clearance on First-Ever Tumor Auto-Contouring Solution for Radiation Therapy

April 7, 2021 — Vysioneer, a leader in artificial intelligence (AI) for cancer care, announced it received the U.S. Food ...

Time April 07, 2021
arrow
The National Comprehensive Cancer Network® (NCCN®) and the American Cancer Society (ACS) are teaming up with leading health organizations across the country to endorse the safe resumption of cancer screening and treatment during the ongoing COVID-19 pandemic.
News | Radiation Therapy
ASTRO Survey Finds Pandemic Has Led to More Advanced-stage Cancer Diagnoses

March 31, 2021 — Doctors who oversee cancer clinics say that new patients are arriving for treatment with more advanced ...

Time March 31, 2021
arrow
Ultimately, because LYFS-CT may exclude minority patients who could benefit from LCS and underestimate the benefits of LCS, the authors of this AJR article suggested "augmenting LCS eligibility for minority patients using combinations of models"--specifically, the PLCOm2012 model in conjunction with LYFS-CT and USPSTF-2020. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)
News | Lung Imaging
Risk Prediction to Reduce Minority Disparities in USPSTF Lung Cancer Screening Guidelines

March 29, 2021 — According to ARRS' American Journal of Roentgenology (AJR), updated United States Preventive Services ...

Time March 29, 2021
arrow
Shine executives are joined by the company’s construction managers and partners at its medical isotope production facility. The group was commemorating the facility’s achievement of weathertight status
News | Radiopharmaceuticals and Tracers
Shine Medical Announces its Isotope Production Facility is Weathertight

March 26, 2021 — Shine Medical Technologies LLC announced that construction of the exterior structure of its first-of-a ...

Time March 26, 2021
arrow
Boston Scientific Corporation announced positive data from the TARGET study of the TheraSphere Y-90 Glass Microspheres (TheraSphere) – a type of radioembolization comprised of millions of microscopic glass beads containing radioactive yttrium (Y-90) – during a late-breaking clinical trial presentation at the annual scientific meeting for the Society of Interventional Radiology (SIR).
News | Interventional Radiology
Late-Breaking Clinical Trial Data for TheraSphere Y-90 Glass Microspheres Demonstrates Improved Survival in Primary Liver Cancer

March 25, 2021 — Boston Scientific Corporation announced positive data from the TARGET study of the TheraSphere Y-90 ...

Time March 25, 2021
arrow
Sun Nuclear Corporation announced that Australia's Northern Sydney Cancer Centre (NSCC) is now a reference site for the SunCHECK Quality Management Platform.
News | Radiation Therapy
Northern Sydney Cancer Centre Partners with Sun Nuclear as Newest SunCHECK Platform Reference Site

March 25, 2021 — Sun Nuclear Corporation announced that Australia's Northern Sydney Cancer Centre (NSCC) is now a ...

Time March 25, 2021
arrow
A new study led by Ivan Martinez—associate professor in the WVU School of Medicine and Cancer Institute—found a link between a family of RNAs, the Y chromosome, and radiation sensitivity in male lung-cancer patients
News | Radiation Therapy
Loss of Y chromosome, RNA Tied to Radiation Resistance in Male Lung-cancer Patients

March 23, 2021 — The science behind the COVID-19 vaccine has the potential to do more than prevent cases of COVID-19 ...

Time March 23, 2021
arrow
Cancer tissue being bombarded by targeted alpha particles. The generator developed by Los Alamos National Laboratory holds uranium-230, which decays to thorium-226. Further decay produces short-lived daughter isotopes, emitting four more alpha particles resulting in a very high combined radiation dose to destroy cancer cells.
News | Radiation Therapy
New Los Alamos Generator System Delivers Large Radiation Doses Directly to Cancer Cells

March 23, 2021 — Improved options for cancer treatment are on the way, thanks to a new system developed at Los Alamos ...

Time March 23, 2021
arrow
Detection of tumor-infiltrating lymphocytes (TILs) using explainable AI. The AI-technique is used to generate a heatmap showing TILs (red) and other tissues and cells (blue and green). Image courtesy of Klauschen/Charité
News | Artificial Intelligence
Making the Role of AI in Breast Cancer Explainable

March 22, 2021 — Researchers at Charité - Universitätsmedizin Berlin and TU Berlin as well as the University of Oslo ...

Time March 22, 2021
arrow
Radiofrequency ablation for the palliative treatment of osseous metastases reduces pain and improves quality of life
News | Interventional Radiology
Minimally Invasive Treatment Provides Fast Pain Relief for Cancer Patients

March 19, 2021 — A minimally invasive treatment for patients whose cancer has spread to their bones provides quick and ...

Time March 19, 2021
arrow
Boston Scientific's TheraSphere Y-90 Glass Microspheres enable selective internal radiation therapy (SIRT), or radioembolization, for hepatocellular carcinoma. This treats liver cancer with low toxicity using millions of microscopic glass beads containing radioactive yttrium (Y-90), delivered directly to liver tumors via catheter. The result in minimal radiation exposure to surrounding healthy tissue.
News | Radiation Therapy
FDA Clears Boston Scientific TheraSphere Y-90 Transcatheter Liver Embolization Microspheres

March 18, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Boston Scientific's TheraSphere Y-90 Glass ...

Time March 18, 2021
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now